TORL BioTherapeutics, LLC
0 followers
A clinical-stage biopharmaceutical company advancing the development of new biologics for cancer treatment. TORL-Bio was founded in 2018 and is focused on the development of novel antibody-based therapeutics for cancer patients. TORL has currently 3 therapeutics in Ph1 clinical trials in indicatio... Read more
Org chart
Mark Alles
Chief Executive Officer
Mark Alles
Collapse
Stephen Letrent
Chief Development Officer
Lee Sailor
Chief Administrative Officer
Bilqees Akhtar
Vice President, Head Of Regulatory Affairs
Iris Sison
Associate Vice President Clinical Operations
Nekesha Kyle
Director Of Global Operations And Supply Chain
